A detailed history of Well Done, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Well Done, LLC holds 391 shares of LLY stock, worth $361,170. This represents 0.07% of its overall portfolio holdings.

Number of Shares
391
Previous 411 4.87%
Holding current value
$361,170
Previous $319,000 10.97%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$724.87 - $909.04 $14,497 - $18,180
-20 Reduced 4.87%
391 $354,000
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $243,394 - $325,627
411 New
411 $319,000
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $2,114 - $2,489
-19 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $2,012 - $2,254
19 New
19 $2,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $878B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Well Done, LLC Portfolio

Follow Well Done, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Well Done, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Well Done, LLC with notifications on news.